Skip to main content
Log in

Local Control of Perivascular Malignant Liver Lesions Using Percutaneous Irreversible Electroporation: Initial Experiences

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

This study was designed to assess efficacy and safety in the treatment of perivascular malignant liver lesions using percutaneous, computed tomography (CT)-guided irreversible electroporation (IRE).

Methods

Fourteen patients (mean age 58 ± 11 years) with 18 malignant liver lesions were consecutively enrolled in this study. IRE was performed in patients not eligible for surgery and lesions abutting large vessels or bile ducts. Follow-up exams were performed using multislice-CT (MS-CT) or MRI.

Results

Medium lesion diameter was 20 ± 5 mm. Ten of 14 (71 %) were successfully treated with no local recurrence to date (mean follow-up 388 ± 160 days). One case left initial tumor control unclear and additional RFA was performed 4 weeks after IRE. Complications occurred in 4 of 14 (29 %) cases. In one case, intervention was terminated and abdominal bleeding required laparotomy. In two cases, a postinterventional hematothorax required intervention. In another case, abdominal bleeding could be managed conservatively. No complications related to the bile ducts occurred.

Conclusions

Percutaneous IRE seems to be effective in perivascular lesions but is associated with a higher complication rate compared with thermoablative techniques.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Davalos RV, Mir IL, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33:223–231

    Article  CAS  PubMed  Google Scholar 

  2. Appelbaum L, Ben-David E, Faroja M et al (2014) Irreversible electroporation ablation: creation of large-volume ablation zones in in vivo porcine liver with four-electrode arrays. Radiology 270(2):416–424

    Article  PubMed  Google Scholar 

  3. Edd JF, Horowitz L, Davalos RV et al (2006) In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 53:1409–1415

    Article  PubMed  Google Scholar 

  4. Rubinsky B (2007) Irreversible electroporation in medicine. Technol Cancer Res Treat 6:255–260

    Article  PubMed  Google Scholar 

  5. Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat 6:37–48

    Article  PubMed  Google Scholar 

  6. Sun QK, Wang W, Jia WD (2014) Radiofrequency ablation is a valuable therapeutic option in the treatment of liver metastases from gastrointestinal stromal tumors. Cardiovasc Intervent Radiol 37(2):552–553

    Article  PubMed  Google Scholar 

  7. Lee DH, Lee JM, Lee JY et al (2013) Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis. Cardiovasc Intervent Radiol. doi:10.1007/s00270-013-0708-x (in press)

  8. Di Vece F, Tombesi P, Ermili F et al (2013) Coagulation areas produced by cool-tip radiofrequency ablation and microwave ablation using a device to decrease back-heating effects: a prospective pilot study. Cardiovasc Intervent Radiol. doi: 10.1007/s00270-013-0733-9 (in press)

  9. Ahmed M, Brace CL, Lee FT Jr et al (2011) Principles of and advances in percutaneous ablation. Radiology 258:351–369

    Article  PubMed  Google Scholar 

  10. Crocetti L, Lencioni R (2008) Thermal ablation of hepatocellular carcinoma. Cancer Imaging 8:19–26

    Article  PubMed Central  PubMed  Google Scholar 

  11. Faroja M, Ahmed M, Appelbaum L et al (2013) Irreversible electroporation ablation: is all the damage nonthermal? Radiology 266:462–470

    Article  PubMed  Google Scholar 

  12. Cannon R, Ellis S, Hayes D et al (2013) Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol 107:544–549

    Article  PubMed  Google Scholar 

  13. Lee YJ, Lu DS, Osuagwu F et al (2012) Irreversible electroporation in porcine liver: short- and long-term effect on the hepatic veins and adjacent tissue by CT with pathological correlation. Investig Radiol 47:671–675

    Article  Google Scholar 

  14. Maor E, Ivorra A, Leor J et al (2007) The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 6:307–312

    Article  PubMed  Google Scholar 

  15. Choi JW, Lu DS, Osuagwu F et al (2014) Assessment of chronological effects of irreversible electroporation on hilar bile ducts in a porcine model. Cardiovasc Intervent Radiol 37(1):224–230

    Article  PubMed  Google Scholar 

  16. Kingham TP, Karkar AM, D’Angelica MI et al (2012) Ablation of perivascular hepatic malignant tumors with irreversible electroporation. J Am Coll Surg 215:379–387

    Article  PubMed  Google Scholar 

  17. Niessen C, Jung EM, Wohlgemuth WA et al (2013) Irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft. Korean J Radiol 14:797–800

    Article  PubMed Central  PubMed  Google Scholar 

  18. Lu DS, Raman SS, Vodopich DJ et al (2002) Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effect. AJR Am J Roentgenol 178:47–51

    Article  PubMed  Google Scholar 

  19. Cheung W, Kavnoudias H, Roberts S et al (2013) Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes. Technol Cancer Res Treat 12:233–241

    CAS  PubMed  Google Scholar 

  20. Deodhar A, Monette S, Single GW Jr et al (2011) Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model. Urology 77:754–760

    Article  PubMed  Google Scholar 

  21. Wendler JJ, Porsch M, Huhne S et al (2013) Short- and mid-term effects of irreversible electroporation on normal renal tissue: an animal model. Cardiovasc Intervent Radiol 36:512–520

    Article  CAS  PubMed  Google Scholar 

  22. Martin RC II, McFarland K, Ellis S et al (2013) Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol 20(Suppl 3):443–449

    Article  Google Scholar 

  23. Martin RC II, McFarland K, Ellis S et al (2012) Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma. J Am Coll Surg 215:361–369

    Article  PubMed  Google Scholar 

  24. Neal RE II, Rossmeisl JH Jr, Garcia PA et al (2011) Successful treatment of a large soft tissue sarcoma with irreversible electroporation. J Clin Oncol 29:e372–e377

    Article  PubMed  Google Scholar 

  25. Charpentier KP (2012) Irreversible electroporation for the ablation of liver tumors: are we there yet? Arch Surg 147:1053–1061

    Article  PubMed  Google Scholar 

  26. Silk MT, Wimmer T, Lee KS et al (2014) Percutaneous ablation of peribiliary tumors with irreversible electroporation. J Vasc Interv Radiol 25:112–118

    Article  PubMed  Google Scholar 

  27. Kasivisvanathan V, Thapar A, Oskrochi Y et al (2012) Irreversible electroporation for focal ablation at the porta hepatis. Cardiovasc Intervent Radiol 35:1531–1534

    Article  PubMed  Google Scholar 

  28. Philips P, Hays D, Martin RC (2013) Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated. PLoS One 8:e76260

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Ben-David E, Appelbaum L, Sosna J et al (2012) Characterization of irreversible electroporation ablation in in vivo porcine liver. AJR Am J Roentgenol 198:W62–W68

    Article  PubMed  Google Scholar 

  30. Bruix J, Sherman M, Practice Guidelines Committee AAftSoLD (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236

    Article  PubMed  Google Scholar 

  31. Sun QK, Wang W, Jia WD (2014) Radiofrequency ablation is a valuable therapeutic option in the treatment of liver metastases from gastrointestinal stromal tumors. Cardiovasc Intervent Radiol 37(2):552–553

    Article  PubMed  Google Scholar 

  32. Poggi G, Montagna B, DIC P et al (2013) Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results. Anticancer Res 33:1221–1227

    PubMed  Google Scholar 

  33. Vogl TJ, Dommermuth A, Heinle B et al (2014) Colorectal cancer liver metastases: long-term survival and progression-free survival after thermal ablation using magnetic resonance-guided laser-induced interstitial thermotherapy in 594 patients: analysis of prognostic factors. Investig Radiol 49(1):48–56

    Article  CAS  Google Scholar 

  34. Vogl TJ, Freier V, Nour-Eldin NE et al (2013) Magnetic resonance-guided laser-induced interstitial thermotherapy of breast cancer liver metastases and other noncolorectal cancer liver metastases: an analysis of prognostic factors for long-term survival and progression-free survival. Investig Radiol 48:406–412

    Article  Google Scholar 

  35. Mulier S, Ni Y, Jamart J et al (2005) Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242:158–171

    Article  PubMed Central  PubMed  Google Scholar 

  36. Charpentier KP, Wolf F, Noble L et al (2011) Irreversible electroporation of the liver and liver hilum in swine. HPB (Oxford) 13:168–173

    Google Scholar 

  37. Minami Y, Kudo M (2013) Radiofrequency ablation of liver metastases from colorectal cancer: a literature review. Gut Liver 7:1–6

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Vogl TJ, Zegelman A, Bechstein WO et al (2013) Treatment of liver metastases of colorectal carcinoma: overview of hyperthermal ablation methods. Dtsch Med Wochenschr 138:792–798

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

Achim Eller, Axel Schmid, Joachim Schmidt, Matthias May, Michael Brand, Marc Saake, Michael Uder, and Michael Lell declare that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Achim Eller.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eller, A., Schmid, A., Schmidt, J. et al. Local Control of Perivascular Malignant Liver Lesions Using Percutaneous Irreversible Electroporation: Initial Experiences. Cardiovasc Intervent Radiol 38, 152–159 (2015). https://doi.org/10.1007/s00270-014-0898-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-014-0898-x

Keywords

Navigation